Livzon Pharmaceutical Group(LVZPF)
$3.800.00 (0.00%)
LVZPF
Livzon Pharmaceutical Group financials statements
$3.80
At close:0.00 (0.00%)
Livzon Pharmaceutical Group (LVZPF) Income Statement
5 Followers
Livzon Pharmaceutical Group Income Statement
Last quarter (Q3 2026), Livzon Pharmaceutical Group's total revenue was ¥2.32B, a decrease of 18.42% from the same quarter last year. In Q3, Livzon Pharmaceutical Group's net income was ¥355.85M. See Livzon Pharmaceutical Group’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 12.02B | ¥ 11.81B | ¥ 12.43B | ¥ 12.63B | ¥ 12.06B | |
| ¥ 7.92B | ¥ 7.73B | ¥ 7.66B | ¥ 8.17B | ¥ 7.81B | |
| ¥ 4.97B | ¥ 4.89B | ¥ 5.24B | ¥ 5.93B | ¥ 5.62B | |
| Depreciation and Amortization | ¥ 539.01M | ¥ 575.14M | ¥ 840.32M | ¥ 652.32M | ¥ 445.27M |
| ¥ 3.10B | ¥ 3.47B | ¥ 3.33B | ¥ 3.08B | ¥ 2.77B | |
| ¥ 2.95B | ¥ 2.84B | ¥ 2.42B | ¥ 2.35B | ¥ 2.27B | |
| ¥ -84.07M | ¥ -38.25M | ¥ -32.44M | ¥ -20.01M | ¥ -21.30M | |
| ¥ 2.86B | ¥ 2.81B | ¥ 2.38B | ¥ 2.33B | ¥ 2.25B | |
| ¥ 2.02B | ¥ 2.06B | ¥ 1.95B | ¥ 1.91B | ¥ 1.78B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 2.27 | ¥ 2.24 | ¥ 2.10 | ¥ 2.04 | ¥ 1.90 |
| Diluted EPS | ¥ 2.27 | ¥ 2.24 | ¥ 2.10 | ¥ 2.04 | ¥ 1.90 |
| Weighted Average Shares Outstanding | 893.10M | 920.13M | 930.31M | 933.86M | 934.46M |
| Weighted Average Shares Outstanding (Diluted) | 893.10M | 920.13M | 930.61M | 935.98M | 934.57M |
Currency in CNY

